Sleep Apnea Devices Market

The report "Sleep Apnea Devices Market by products (Therapeutic (PAP (CPAP, APAP, BPAP)), Facial Interfaces, Oral Appliances, Accessories), Diagnostic Devices (PSG, Home Sleep Testing, Oximeters), Age Group, Gender type, End User & Region - Global Forecasts to 2029", is valued at an estimated USD 6.5 billion in 2024 and is projected to reach USD 9.3 billion by 2029 at a CAGR of 7.3% during the forecast period.

Browse 483 market data Tables and 50 Figures spread through 366 Pages and in-depth TOC on "Sleep Apnea Devices Market by products (Therapeutic (PAP (CPAP, APAP, BPAP)), Facial Interfaces, Oral Appliances, Accessories), Diagnostic Devices (PSG, Home Sleep Testing, Oximeters), Age Group, Gender type, End User & Region - Global Forecasts to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/sleep-apnea-devices-market-719.html

In recent years, there has been substantial growth in the sleep apnea devices market, driven primarily by the rising availability and adoption of home sleep testing products in the market. Home sleep testing products are revolutionizing the sleep apnea market by offering convenient, cost-effective, and accessible diagnostic solutions for patients. However, poor compliance with CPAP devices that limits effectiveness may restrain the growth of sleep apnea devices market during forecast period.

In 2023, the therapeutic devices segment held the largest share of the sleep apnea devices market by product segment.

Based on product, the sleep apnea devices market has been segmented into therapeutic devices and diagnostic devices. The therapeutic devices segment dominated the sleep apnea devices market in 2023 due to advancement in devices to increase comfort and ease of use to improve the patient adherence fr sleep apnea therapy. Major players in this segment include ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare Limited (New Zealand).

The home care settings/individuals held the largest share of the sleep apnea devices market by end user segment in 2023.

Based on end user, the sleep apnea devices market is segmented into sleep laboratories, clinics, and hospitals and home care settings/individuals. In 2023, the largest share of the sleep apnea devices market was held by the home care settings/individuals. The accessibility which eliminates the need for patients to travel to sleep centers, making diagnosis and treatment more accessible, attracts the growth of this market.

North America is the largest regional market for sleep apnea devices market.

The market for sleep apnea devices has been divided into six key geographical regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. For the year 2023, North America has been estimated to hold the predominant portion of the sleep apnea devices market. The growth in the North American sleep apnea devices market is majorly driven by higher public awareness and availability along with accessibility of advanced diagnostic techniques in North America propelling market growth. Improving reimbursement scenarios are also expected to drive market adoption of sleep apnea devices.

The major players operating in this market are ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare Limited (New Zealand), Inspire Medical Systems, Inc. (US), SomnoMed (Australia), Openairway (Canada), Compumedics Limited (Australia), Löwenstein Medical Technology GmbH + Co. K.G. (Germany), Drive DeVilbiss Healthcare (US), BMC Medical Co., Ltd. (China), BRAEBON Medical Corporation (Canada), DynaFlex (US), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Tomed GmbH (Germany), LivaNova PLC (UK), Invacare Corporation (US), MPowrx Health & Wellness Products Inc. (Canada), Nihon Kohden Corporation (Japan), SICAT GmbH & Co. Kg (Germany), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US).

Don’t miss out on business opportunities in Sleep Apnea Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]